Clusterin overexpression and relapse-free survival in breast cancer

Anticancer Research

Volumn 29, Issue 10, 2009, Pages 3909-3912

  Yom, Cha Kyong ^a   Woo, Hee Yeon ^a   Min, Sun Young ^b   Kang, So Young ^b   Kim, Hee Sung ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b NONE

Author keywords

Breast; Carcinoma; Clusterin; Relapse free survival

Indexed keywords

CLUSTERIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; BREAST NEOPLASMS; CLUSTERIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; SURVIVAL RATE;

EID: 71949122628     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Trougakos IP and Gonos ES: Clusterin/apolipoprotein J in human aging and cancer. Int J Biochem Cell Biol 34: 1430-1448, 2002.
2. Zhang H, Kim JK, Edwards CA, Xu Z, Taichman R and Wang CY: Clusterin inhibits apoptosis by interacting with activated Bax. Nat Cell Biol 7: 909-915, 2005. (Pubitemid 41486292)
3. Miyake H, Nelson C, Rennie PS and Gleave ME: Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. Cancer Res 60: 170-176, 2000. (Pubitemid 30058748)
4. Pucci S, Bonanno E, Pichiorri F, Angeloni C and Spagnoli LG: Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene 23: 2298-2304, 2004. (Pubitemid 38496784)
5. Redondo M, Villar E, Torres-Munoz J, Tellez T, Morell M and Petito CK: Overexpression of clusterin in human breast carcinoma. Am J Pathol 157: 393-399, 2000. (Pubitemid 30626904)
6. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG and Morrow M: AJCC Cancer Staging Manual, 2002.
7. Toffanin S, Daidone MG, Miodini P, De Cecco L, Gandellini P and Cappelletti V: Clusterin: a potential target for improving response to antiestrogens. Int J Oncol 33: 791-798, 2008.
8. So A, Sinnemann S, Huntsmann D, Fazli L and Gleave M: Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo. Mol Cancer Ther 4: 1837-1849, 2005.
9. Redondo M, Tellez T, Roldan M, Serrano A, García-Aranda M, Gleave ME, Hortas ML and Morell M: Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity. Breast Cancer Res 9: R86, 2007.